Cargando…
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2
The rapid emergence and global dissemination of SARS-CoV-2 that causes COVID-19 continues to cause an unprecedented global health burden resulting in nearly 7 million deaths. While multiple vaccine countermeasures have been approved for emergency use, additional treatments are still needed due to sl...
Autores principales: | Weiss, Christopher M., Liu, Hongwei, Ball, Erin E., Hoover, Ashley R., Wong, Talia S., Wong, Chun Fung, Lam, Samuel, Hode, Tomas, Keel, M. Kevin, Levenson, Richard M., Chen, Wei R., Coffey, Lark L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409267/ https://www.ncbi.nlm.nih.gov/pubmed/37552656 http://dx.doi.org/10.1371/journal.pone.0289139 |
Ejemplares similares
-
N-Dihydrogalactochitosan Potentiates the Radiosensitivity of Liver Metastatic Tumor Cells Originated from Murine Breast Tumors
por: Wang, Chung-Yih, et al.
Publicado: (2019) -
Engineering a fidelity-variant live-attenuated vaccine for chikungunya virus
por: Weiss, Christopher M., et al.
Publicado: (2020) -
Severe Acute Respiratory Syndrome Coronavirus 2 Vasculopathy in a Syrian Golden Hamster Model
por: Ball, Erin E., et al.
Publicado: (2023) -
Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory
por: Qi, Shuhong, et al.
Publicado: (2020) -
Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy
por: Korbelik, Mladen, et al.
Publicado: (2021)